Vol 8, No 2 (April 18, 2017): Journal of Gastrointestinal Oncology (Optimizing the management of hepatobiliary neoplasms: a multidisciplinary and molecular challenge)

Review Article

Locoregional and systemic therapy for hepatocellular carcinoma
Olumide B. Gbolahan, Michael A. Schacht, Eric W. Beckley, Thomas P. LaRoche, Bert H. O’Neil, Maximilian Pyko
Viral hepatitis and hepatocellular carcinoma: etiology and management
Philippe J. Zamor, Andrew S. deLemos, Mark W. Russo
Systemic therapy for advanced hepatocellular carcinoma: an update
Jasmin Radhika Desai, Sebastian Ochoa, Petra Alexandra Prins, Aiwu Ruth He
Hepatocellular carcinoma (HCC): beyond sorafenib—chemotherapy
Dae Won Kim, Chetasi Talati, Richard Kim
Selective internal radiation therapy with SIR-Spheres in hepatocellular carcinoma and cholangiocarcinoma
Eric A. Wang, Scott R. Broadwell, Ross J. Bellavia, Jeff P. Stein
Radiation therapy for hepatobiliary malignancies
Jonathan W. Lischalk, Michael C. Repka, Keith Unger
Biliary cancer: intrahepatic cholangiocarcinoma vs. extrahepatic cholangiocarcinoma vs. gallbladder cancers: classification and therapeutic implications
Daniel H. Ahn, Tanios Bekaii-Saab
Adjuvant therapy in biliary tract and gall bladder carcinomas: a review
Roshan S. Prabhu, Jimmy Hwang
Chemotherapy in patients with hepatobiliary cancers and abnormal hepatic function
Jun Gong, May Cho, Marwan Fakih
Targeted therapy in biliary tract cancers—current limitations and potentials in the future
Selley Sahu, Weijing Sun

Original Article

Operative microwave ablation for hepatocellular carcinoma: a single center retrospective review of 219 patients
Erin H. Baker, Kyle Thompson, Iain H. McKillop, Allyson Cochran, Russell Kirks, Dionisios Vrochides, John B. Martinie, Ryan Z. Swan, David A. Iannitti
Systemic therapy for unresectable, mixed hepatocellular-cholangiocarcinoma: treatment of a rare malignancy
Jane E. Rogers, Ryan M. Bolonesi, Asif Rashid, Khaled M. Elsayes, Mohamed G. Elbanan, Lindsey Law, Ahmed Kaseb, Rachna T. Shroff
Long term responders to palliative chemotherapy for advanced biliary tract cancer
Mark K. Doherty, Mairéad G. McNamara, Priya Aneja, Emma McInerney, Stephanie Moignard, Anne M. Horgan, Haiyan Jiang, Tony Panzarella, Raymond Jang, Neesha Dhani, David Hedley, Jennifer J. Knox
Concurrent chemoradiation with volumetric modulated Arc therapy of patients treated for anal cancer—acute toxicity and treatment outcome
Kaloyan Yordanov, Simona Cima, Antonella Richetti, Gianfranco Pesce, Francesco Martucci, Ngwa Che Azinwi, Maria Carla Valli
Treatment of advanced Gall bladder cancer in the real world—can continuation chemotherapy improve outcomes?
Vikas Ostwal, Rakesh Pinninti, Anant Ramaswamy, Nitin Shetty, Mahesh Goel, Shraddha Patkar, Jimmy Mirani, Chaitali Nashikkar, Shripad Banavali

Disclosure:

The focused issue “Optimizing the management of hepatobiliary neoplasms: a multidisciplinary and molecular challenge” was commissioned by the Editorial office, Journal of Gastrointestinal Oncology without any sponsorship or funding. Jimmy J. Hwang served as the unpaid Guest Editor for the focused issue.